Skip to main content
TLSA
NASDAQ Life Sciences

Tiziana Files for FDA Orphan Drug Designation for Intranasal Foralumab in MSA

Tom Rudovsky · Reported by GlobeNewswire
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$1.01
Mkt Cap
$122.368M
52W Low
$0.762
52W High
$2.33
52W Position info
33% above low
Off High info
57% below high
Rel. Volume info
0.8× avg
Market data snapshot near publication time

TLSA sits 33% above its 52-week low of $0.762.

Summary

Tiziana has submitted a request to the FDA for Orphan Drug Designation for intranasal foralumab in Multiple System Atrophy (MSA), a rare neurodegenerative disease with no approved disease-modifying therapies. If granted, the designation would provide seven years of market exclusivity, tax credits, and fee waivers. The company is already running a Phase 2a trial in MSA, with PET imaging data from the third patient reported in July showing up to a 34% reduction in neuroinflammation. This filing is a logical next step and could strengthen the commercial outlook for the lead asset. FDA review of the request typically takes up to 90 days.

Updates

  1. · SEC 6-K — The 6-K attaches the press release announcing the orphan drug designation request for intranasal foralumab in MSA.

At the time of this announcement, TLSA was trading at $1.01 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $122.4M. The 52-week trading range was $0.76 to $2.33. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: GlobeNewswire.


Price Chart

Share this article

Copied!

TLSA - Latest Insights

TLSA
Nov 02, 2026, 7:00 AM EST
Filing Type: 6-K
Importance Score:
9
Price at Filing: $0.890
Real-time Price: $0.71365 info
Change: -$0.17635 (-20%) info
Market Cap: $91.568M info
TLSA
Nov 02, 2026, 7:00 AM EST
Source: GlobeNewswire
Importance Score:
9
Price at Filing: $0.8685
Real-time Price: $0.71365 info
Change: -$0.15485 (-18%) info
Market Cap: $91.568M info
TLSA
Oct 16, 2026, 4:30 PM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $1.05
Real-time Price: $0.71365 info
Change: -$0.33635 (-32%) info
Market Cap: $91.568M info
TLSA
Oct 16, 2026, 7:00 AM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $1.07
Real-time Price: $0.71365 info
Change: -$0.35635 (-33%) info
Market Cap: $91.568M info
TLSA
Sep 30, 2026, 7:00 AM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $1.00
Real-time Price: $0.71365 info
Change: -$0.28635 (-29%) info
Market Cap: $91.568M info